Copart, Inc. (CPRT) Market Cap & Valuation Ratios
Copart, Inc. (CPRT) has a market cap of $26.9B, a trailing P/E of 18.7 and a price-to-sales ratio of 5.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
CPRTCopart, Inc.Follow CPRT — free
—
Price chart with a free account
- Market cap
- 26.9B
- P/E TTM
- 18.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
Peers
specialty business services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CPRT | 27 | 18.7 | 5.3 | 13.2 | 4.7% | +0.4% | 35% | 20% |
| CTAS | 89 | 44.2 | 7.9 | 28.4 | 2.3% | +10% | 23% | 30% |
| TRI | 61 | 33.0 | 8.2 | 27.3 | 3.6% | +91% | 30% | 13% |
| SE | 46 | 29.6 | 1.6 | 15.6 | 9.9% | +36% | 9% | 14% |
| TCOM | 26 | — | — | — | — | +15% | 25% | 8% |
| GPN | 22 | — | 3.9 | 11.0 | 3.8% | +33% | 12% | 3% |
| RBA | 16 | 36.3 | 3.7 | 14.0 | 3.9% | +10% | 16% | 8% |
| ULS | 15 | 29.6 | 4.7 | 19.5 | 2.9% | +7% | 18% | 29% |
| ARMK | 14 | 37.0 | 1.0 | 14.0 | 3.1% | +11% | 4% | 7% |
| WSE | 14 | — | — | — | — | +19% | 24% | — |
| ANDG | 7.2 | — | 8.0 | — | 2.3% | +15% | -7% | — |
| Median of these 10 | 34.7 | 4.3 | 15.6 | 3.4% | +15% | 17% | 11% |
P/E 18.7 vs. a peer median of 34.7; EV/Sales 5.3 vs. 4.3. CPRT's own P/E sits at the 19th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesTCOM and GPN and WSE and ANDG have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Copart, Inc. — questions
- What is Copart, Inc.'s market cap?
- $26.9B.
- What is Copart, Inc.'s P/E ratio?
- 18.7 on trailing twelve-month earnings to 2026-07-31.
- What is Copart, Inc.'s price-to-sales ratio?
- 5.8.
Every figure on this page comes from Copart, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.